Systemic therapy for laryngeal carcinoma

Systemic therapy for laryngeal carcinoma

Laryngeal squamous cell carcinoma (LSCC) accounts for 100,000 deaths worldwide each year. Despite multimodal treatment, outcomes for both high-risk locally advanced and recurrent/metastatic laryngeal carcinoma remain poor. Treatment intensification through induction chemotherapy has not improved ove...

Full description

Saved in:
Bibliographic Details
Main Authors: Thorsten Fuereder, Florian Kocher, Jan Baptist Vermorken
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
laryngeal squamous cell carcinoma
head and neck squamous cell carcinoma
immunotherapy
larynx preservation
neoadjuvant
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1541385/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items